Nausea & vomiting in end-stage cancer.
Haughney
Anne
A
Memorial Sloan-Kettering Cancer Center, New York City, USA. haughnea@mskcc.org
D000932:Antiemetics / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use; D015984:Causality; D003907:Dexamethasone / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007415:Intestinal Obstruction / Q000209:etiology / Q000517:prevention & control; D019586:Intracranial Hypertension / Q000209:etiology / Q000517:prevention & control; D008875:Middle Aged; D009325:Nausea / Q000209:etiology / Q000517:prevention & control; D009369:Neoplasms / Q000150:complications*; D009730:Nursing Assessment; D010166:Palliative Care / Q000379:methods* / Q000523:psychology / Q000592:standards; D017410:Practice Guidelines as Topic; D011788:Quality of Life; D012064:Relaxation Therapy; D012702:Serotonin Antagonists / Q000627:therapeutic use; D014839:Vomiting / Q000209:etiology / Q000517:prevention & control
D000932:Antiemetics; D012702:Serotonin Antagonists; D003907:Dexamethasone